NEWS
Ally Bridge Group invests in China's Oncology Big Data Company, LinkDoc Technology
April 19, 2016
Beijing - Paul Hastings, a leading global law firm, announced today that the firm represented Ally Bridge Group (“ABG”), a global healthcare-focused investment group, in its Series B investment into LinkDoc Technology Limited ("LinkDoc"), a leading oncology big data company based in China, alongside other leading Chinese and international investors.
This is the latest in a series of transactions in which the firm has advised clients in the healthcare and pharmaceutical sector. We advised Harmonicare on its global offering and Hong Kong listing. We also advised Livzon Pharmaceutical Group on its B-to-H share listing, and on Phoenix Healthcare Group’s multiple share placements.
The Paul Hastings team was led by partner Nan Li, with support from associate Joyce Du.
At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.
Practice Areas
SIGN UP FOR NEWS INSIGHTS
MEDIA CONTACTS
M&A, Private Equity, Data Privacy and Cybersecurity, Investment Funds and Private Capital, Structured Credit, Life Sciences, Employment Law and Media and Entertainment
Natalie GewargisAntitrust and Competition, Global Finance, Litigation, Financial Restructuring, Intellectual Property, Fintech and Payments, Consumer Financial Services, International Arbitration, and Investigations and White Collar Defense
Becca Hatton